Euclid Advisors’s Johnson & Johnson JNJ Stock Holding History

Euclid Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-177,453	Closed	-$21.5M	–	250
2016 Q2	$21.5M	Buy	177,453 +41,200	+30%	+$4.68M	0.94%	8
2016 Q1	$14.7M	Sell	136,253 -11,181	-8%	-$1.16M	0.56%	46
2015 Q4	$15.1M	Buy	+147,434	New	+$14.8M	0.46%	69
2015 Q3	–	Sell	-223,540	Closed	-$21.8M	–	336
2015 Q2	$21.8M	Sell	223,540 -788,710	-78%	-$79M	0.43%	69
2015 Q1	$102M	Buy	+1,012,250	New	+$103M	1.87%	6
2014 Q4	–	Sell	-1,434,300	Closed	-$153M	–	441
2014 Q3	$153M	Buy	1,434,300 +90,610	+7%	+$9.4M	1.1%	10
2014 Q2	$141M	Sell	1,343,690 -217,711	-14%	-$22M	0.99%	12
2014 Q1	$153M	Buy	1,561,401 +430,980	+38%	+$40M	1.16%	10
2013 Q4	$104M	Sell	1,130,421 -54,060	-5%	-$4.98M	0.86%	15
2013 Q3	$103M	Buy	1,184,481 +246,506	+26%	+$22.1M	1.04%	11
2013 Q2	$80.5M	Buy	+937,975	New	+$79.6M	1.02%	12

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Euclid Advisors's JNJ Position: Q3 2016 in Review

Euclid Advisors sold out of Johnson & Johnson (JNJ) in Q3 2016, closing a stake of 177,453 shares — an estimated $21.5M sold.

Euclid Advisors first reported a position in JNJ in Q2 2013 and held it in 11 quarters. The position peaked at $153M in Q1 2014. 2,228 funds tracked by Wall St. Rank hold JNJ as of Q3 2016.

Euclid Advisors reported no remaining Johnson & Johnson position as of Q3 2016 after selling out during the quarter.
Euclid Advisors sold 177,453 Johnson & Johnson shares in Q3 2016, an estimated $21.5M.
Euclid Advisors first reported a position in Johnson & Johnson in Q2 2013 and held it in 11 quarters.
Euclid Advisors's Johnson & Johnson position peaked at $153M in Q1 2014.
2,228 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2016.

Based on Euclid Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.